Hypoxia-inducible factor 1 alpha contributes to cardiac healing in mesenchymal stem cells-mediated cardiac repair

Stem Cells and Development

Volumn 22, Issue 3, 2013, Pages 501-511

  Cerrada, Inmaculada ^a,b   Ruiz Saurí, Amparo ^c   Carrero, Rubén ^a   Trigueros, César ^d   Dorronsoro, Akaitz ^d   Sanchez Puelles, Jose María ^e   Diez Juan, Antonio ^f   Montero, Jose Anastasio ^a   Sepúlveda, Pilar ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d Fundacion Inbiomed   (Spain)

^e CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^f CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LENTIVIRUS VECTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE TARGETING; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR; TISSUE REGENERATION;

ANIMALS; BONE MARROW CELLS; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CORONARY VESSELS; HEART; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, NUDE; REGENERATION; SIGNAL TRANSDUCTION; TRANSCRIPTOME; UP-REGULATION; WOUND HEALING;

LENTIVIRUS; RATTUS;

EID: 84872722077     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0340     Document Type: Article

References (47)

1. Anderson JL,CDAdams, EMAntman,CR Bridges,RMCaliff, DE Casey, Jr., WE Chavey, 2nd, FM Fesmire, JS Hochman, et al. (2011). 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 123:e426-e579.
2. Patel MR, GJ Dehmer, JWHirshfeld, PK Smith, JA Spertus, FA Masoudi, GJ Dehmer, MR Patel, PK Smith, et al. (2012). ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Thorac Cardiovasc Surg 143:780-803.
3. Samper E, A Diez, JA Montero and P Sepú lveda. (2012). Cardiac cell therapy: boosting mesenchymal stem cells effects. Stem Cell Rev. [Epub ahead of print]; DOI:10.1007/s12015-012-9353-Z.
4. Rosova I, M Dao, B Capoccia, D Link and JA Nolta. (2008). Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26:2173-2182.
5. Semenza GL. (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721-732.
6. Lisy K and DJ Peet. (2008). Turn me on: regulating HIF transcriptional activity. Cell Death Differ 15:642-649.
7. Majmundar AJ, WJ Wong and MC Simon. (2010). Hypoxiainducible factors and the response to hypoxic stress. Mol Cell 40:294-309.
8. Wang GL, BH Jiang, EA Rue and GL Semenza. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510-5514.
9. Wenger RH. (2002). Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 16:1151-1162.
10. González IR, V Moreno-Manzano, FJ Rodriguez-Jimenez, P Sepúlveda and JM Sánchez-Puelles. (2011). The biology of HIF proteins in cell differentiation and disease. Vitam Horm 87:367-379.
11. Jiang C, H Lu, KA Vincent, S Shankara, AJ Belanger, SH Cheng, GY Akita, RA Kelly, MA Goldberg and RJ Gregory. (2002). Gene expression profiles in human cardiac cells subjected to hypoxia or expressing a hybrid form of HIF-1 alpha. Physiol Genomics 8:23-32.
12. Kido M, L Du, CC Sullivan, X Li, R Deutsch, SW Jamieson and PA Thistlethwaite. (2005). Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol 46:2116-2124.
13. Loor G and PT Schumacker. (2008). Role of hypoxia-inducible factor in cell survival during myocardial ischemiareperfusion. Cell Death Differ 15:686-690.
14. Pichiule P, JC Chavez and JC LaManna. (2004). Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J Biol Chem 279:12171-12180.
15. Wang GL and GL Semenza. (1993). Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82:3610-3615.
16. Ji L, YX Liu, C Yang,WYue, SS Shi, CX Bai, JF Xi, X Nan and XT Pei. (2009). Self-renewal and pluripotency is maintained in human embryonic stem cells by co-culture with human fetal liver stromal cells expressing hypoxia inducible factor 1alpha. J Cell Physiol 221:54-66.
17. Shyu KG, MT Wang, BW Wang, CC Chang, JG Leu, P Kuan and H Chang. (2002). Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc Res 54:576-583.
18. Liu XB, JA Wang, ME Ogle and L Wei. (2009). Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival. J Cell Biochem 106:903-911.
19. Stubbs SL, ST Hsiao, HM Peshavariya, SY Lim, GJ Dusting and RJ Dilley. (2012). Hypoxic preconditioning enhances survival of human adipose-derived stem cells and conditions endothelial cells in vitro. Stem Cells Dev 21:1887-1896.
20. Zou D, Z Zhang, D Ye, A Tang, L Deng, W Han, J Zhao, S Wang, W Zhang, et al. (2011). Repair of critical-sized rat calvarial defects using genetically engineered bone marrowderived mesenchymal stem cells overexpressing hypoxiainducible factor-1alpha. Stem Cells 29:1380-1390.
21. Gandia C, A Arminan, JM Garcia-Verdugo, E Lledo, A Ruiz, MD Minana, J Sanchez-Torrijos, R Paya, V Mirabet, et al. (2008). Human dental pulp stem cells improve left ventricular function, induce angiogenesis and reduce infarct size in rats with acute myocardial infarction. Stem Cells 26:638-645.
22. Arminan A, C Gandia, JM Garcia-Verdugo, E Lledo, C Trigueros, A Ruiz-Sauri, MD Minana, P Solves, R Paya, JA Montero and P Sepulveda. (2010). Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. J Am Coll Cardiol 55:2244-2253.
23. Tang XL, G Rokosh, SK Sanganalmath, F Yuan, H Sato, J Mu, S Dai, C Li, N Chen, et al. (2010). Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121:293-305.
24. Bekeredjian R, CB Walton, KA MacCannell, J Ecker, F Kruse, JT Outten, D Sutcliffe, RD Gerard, RK Bruick and RV Shohet. (2010). Conditional HIF-1alpha expression produces a reversible cardiomyopathy. PLoS One 5:e11693.
25. Minamishima YA, J Moslehi, N Bardeesy, D Cullen, RT Bronson and WG Kaelin, Jr. (2008). Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111:3236-3244.
26. Parisi Q, GG Biondi-Zoccai, A Abbate, D Santini, F Vasaturo, S Scarpa, R Bussani, AM Leone, A Petrolini, et al. (2005). Hypoxia inducible factor-1 expression mediates myocardial response to ischemia late after acute myocardial infarction. Int J Cardiol 99:337-339.
27. Holscher M, M Silter, S Krull, M von Ahlen, A Hesse, P Schwartz, B Wielockx, G Breier, DM Katschinski and A Zieseniss. (2011). Cardiomyocyte- specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury. J Biol Chem 286:11185-11194.
28. Tsai CC, YJ Chen, TL Yew, LL Chen, JY Wang, CH Chiu and SC Hung. (2011). Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood 117:459-469.
29. Ceradini DJ, AR Kulkarni, MJ Callaghan, OM Tepper, N Bastidas, ME Kleinman, JM Capla, RD Galiano, JP Levine and GC Gurtner. (2004). Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864.
30. Calvani M, A Rapisarda, B Uranchimeg, RH Shoemaker and G Melillo. (2006). Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107:2705-2712.
31. Higgins DF, MP Biju, Y Akai, A Wutz, RS Johnson and VH Haase. (2004). Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 287:F1223-F1232.
32. Kelly BD, SF Hackett, K Hirota, Y Oshima, Z Cai, S Berg-Dixon, A Rowan, Z Yan, PA Campochiaro and GL Semenza. (2003). Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93:1074-1081.
33. Kitajima Y, T Ide, T Ohtsuka and K Miyazaki. (2008). Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. Cancer Sci 99:1341-1347.
34. Ronkainen VP, JJ Ronkainen, SL Hanninen, H Leskinen, JL Ruas, T Pereira, L Poellinger, O Vuolteenaho and P Tavi. (2007). Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 21:1821-1830.
35. Wolf N, W Yang, CE Dunk, I Gashaw, SJ Lye, T Ring, M Schmidt, E Winterhager and A Gellhaus. (2010). Regulation of the matricellular proteins CYR61 (CCN1) and NOV (CCN3) by hypoxia-inducible factor-1{alpha} and transforming-growth factor-{beta}3 in the human trophoblast. Endocrinology 151:2835-2845.
36. Jun JI and LF Lau. (2010). The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 12:676-685.
37. BujakM and NG Frangogiannis. (2007). The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74:184-195.
38. Li TS, M Hayashi, H Ito, A Furutani, T Murata, M Matsuzaki and K Hamano. (2005). Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation 111:2438-2445.
39. Ries C, V Egea, M Karow, H Kolb, M Jochum and P Neth. (2007). MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109: 4055-4063.
40. Grotendorst GR. (1997). Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8:171-179.
41. Bennewith KL, X Huang, CM Ham, EE Graves, JT Erler, N Kambham, J Feazell, GP Yang, A Koong and AJ Giaccia. (2009). The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res 69:775-784.
42. Recchia AG, EM De Francesco, A Vivacqua, D Sisci, ML Panno, S Ando and M Maggiolini. (2011). The G proteincoupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes. J Biol Chem 286:10773-10782.
43. Gang H, Y Hai, R Dhingra, JW Gordon, N Yurkova, Y Aviv, H Li, F Aguilar, A Marshall, E Leygue and LA Kirshenbaum. A novel hypoxia-inducible spliced variant of mitochondrial death gene Bnip3 promotes survival of ventricular myocytes. Circ Res 108:1084-1092.
44. Hattori K, B Heissig, K Tashiro, T Honjo, M Tateno, JH Shieh, NR Hackett, MS Quitoriano, RG Crystal, S Rafii and MA Moore. (2001). Plasma elevation of stromal cellderived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97:3354-3360.
45. Neuss S, E Becher, M Woltje, L Tietze and W Jahnen-Dechent. (2004). Functional expression of HGF and HGF receptor/c-met in adult mesenchymal stem cells suggest arole in cell mobilization, tissue repair and wound healing. Stem cells 22:405-414.
46. Wojakowski W, M Tendera, A Michalowska, M Majka, M Kucia, K Maslankiewicz, R Wyderka, A Ochala and MZ Ratajczak. (2004). Mobilization of CD34/CXCR4 + , CD34/CD117 + , c-met + stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 110:3213-3220.
47. Rajagopalan S, J Olin, S Deitcher, A Pieczek, J Laird, PM Grossman, CK Goldman, K McEllin, R Kelly and N Chronos. (2007). Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience. Circulation 115:1234-1243.